Ausgabe 12/2023
Inhalt (38 Artikel)
Functional similarity of ABP 959 and eculizumab in simulated serum models of aHUS and NMOSD
Helen J. McBride, Ashley Frazer-Abel, Sandra Thiemann, Sonya G. Lehto, Katariina M. Hutterer, Jennifer Liu
Macrophage depletion using clodronate liposomes reveals latent dysfunction of the hematopoietic microenvironment associated with persistently imbalanced M1/M2 macrophage polarization in a mouse model of hemophagocytic lymphohistiocytosis
Takashi Koike, Katsuhiro Miura, Yoshihiro Hatta, Hideki Nakamura, Yoko Hirabayashi, Miyuki Yuda, Tomonori Harada, Shuichi Hirai, Isao Tsuboi, Shin Aizawa
An analysis of sintilimab combined with ruxolitinib as compassionate therapy for 12 adults with EBV-associated hemophagocytic lymphohistiocytosis
Ying Xu, Wenting Li, Jianhe Gan, Xuefeng He, Xiaoping Huang
The clinical spectrum and prognostic factors of Erdheim-Chester disease and mixed Langerhans cell histiocytosis and Erdheim-Chester disease
Jia‑wen Dai, He Lin, Long Chang, Jian Li, Dao-bin Zhou, Xin-xin Cao
E2F1 rs3213150 polymorphism influences cytarabine sensitivity and prognosis in patients with acute myeloid leukemia
Yanfeng Liu, Peng Chen, Ge Chen, Xiaoping Chen
miR-603 promotes cell proliferation and differentiation by targeting TrkB in acute promyelocytic leukemia
Huibo Li, Jinxiao Hou, Yueyue Fu, Yanqiu Zhao, Jie Liu, Dan Guo, Ruiqi Lei, Yiting Wu, Linqing Tang, Shengjin Fan
Hypomethylating agents plus modified priming regimens compared with venetoclax-based regimens based on molecular characteristics for newly diagnosed patients with acute myeloid leukemia: a multi-center cohort study
Guangyang Weng, Jingya Huang, Xin He, Tingting Xue, Linlin Yang, Yu Zhang, Guopan Yu, Zhiqiang Sun, Dongjun Lin, Lan Deng, Xinquan Liang, Jie Xiao, Hongyu Zhang, Ziwen Guo, Hua Jin, Qifa Liu, Xin Du
Real-world analysis of ruxolitinib in myelofibrosis: interim results focusing on patients who were naïve to JAK inhibitor therapy treated within the JAKoMo non-interventional, phase IV trial
Steffen Koschmieder, Susanne Isfort, Clemens Schulte, Lutz Jacobasch, Thomas Geer, Marcel Reiser, Michael Koenigsmann, Bernhard Heinrich, Jürgen Wehmeyer, Eyck von der Heyde, Hans Tesch, Benedikt Gröschl, Petra Bachhuber, Susanne Großer, Heike L. Pahl
Higher expression of programmed cell death 4 (PDCD4) in acute myeloid leukemia is associated with better prognosis after chemotherapy
Hongwei Tang, Ying Chen, Nan Zhang, Jianchuan Deng, Kang Zhou
Association of inflammation and abnormal lipid metabolism with risk of thrombosis and thrombosis progression in patients with polycythemia vera: a retrospective study
Hurong Lai, Yansong Tu, Shan Zhang, Caifeng Liao, Huaijun Tu, Jian Li
A case of sudden hearing loss in a patient with chronic myelomonocytic leukemia
Rodrick Babakhanlou, Marc-Elie Nader, Yesid Alvarado
Causes of death and treatment-related mortality in newly diagnosed childhood acute lymphoblastic leukemia treatment with Chinese Children’s Cancer Group study ALL-2015
Kangkang Liu, Jingbo Shao, Jiaoyang Cai, Jingyan Tang, Shuhong Shen, Fengling Xu, Yuanyuan Ren, Aijun Zhang, Xin Tian, Xiaoqian Lu, Shaoyan Hu, Qun Hu, Hua Jiang, Fen Zhou, Changda Liang, Alex Wing Kwan Leung, Xiaowen Zhai, Chunfu Li, Yongjun Fang, Zhenling Wang, Lu Wen, Hui Yang, Ningling Wang, Hui Jiang
Outcome prediction by interim positron emission tomography and IgM monoclonal gammopathy in diffuse large B-cell lymphoma
Patricia Johansson, Stefan Alig, Julia Richter, Christine Hanoun, Jan Rekowski, Jan Dürig, Bauke Ylstra, Daphne de Jong, Wolfram Klapper, Ash A. Alizadeh, Ulrich Dührsen, Andreas Hüttmann
High prevalence of past hepatitis B virus infection in diffuse large B cell lymphoma: a retrospective study from Italy
Marcella Visentini, Andrea Pica, Giancarlo D’Ippolito, Eleonora Sculco, Francesca La Gualana, Laura Gragnani, Marzia Miglionico, Cesare Mazzaro, Massimo Fiorilli, Stefania Basili, Maurizio Martelli, Alice Di Rocco, Milvia Casato, Giuseppe Gentile, Alessandro Pulsoni
Development and validation of nomogram prognostic model for predicting OS in patients with diffuse large B-cell lymphoma: a cohort study in China
Xiaosheng Li, Qianjie Xu, Cuie Gao, Zailin Yang, Jieping Li, Anlong Sun, Ying Wang, Haike Lei
Prognostic impact of MYD88 and TP53 mutations in diffuse large B Cell lymphoma
Osama Abd El Hameed Ebid, Lobna R. Ezz El Arab, Amr S. Saad, Mai Ezz El Din, Nermeen Mostafa, Menha Swellam
Real-world clinical outcomes in patients with relapsed and refractory multiple myeloma receiving VTD-PACE treatment in the era of monoclonal antibodies
Taku Kikuchi, Nobuhiro Tsukada, Kodai Kunisada, Moe Nomura-Yogo, Yuki Oda, Kota Sato, Tomomi Takei, Mizuki Ogura, Yu Abe, Kenshi Suzuki, Tadao Ishida
c-Myc inhibits LAPTM5 expression in B-cell lymphomas
Yanqing Zhang, Xin Zhang, Yi Zhang, Han Xu, Zichen Wei, Xin Wang, Yan Li, Junrong Guo, Fan Wu, Xiao Fang, Lei Pang, Bin Deng, Duonan Yu
The experience of diagnosis and treatment for TAFRO syndrome
Xiaolong Wu, Xudong Zhang, Siyu Qian, Cunzhen Shi, Xin Li, Xiaoyan Feng, Linan Zhu, Jingjing Ge, Zhaoming Li, Mingzhi Zhang
Clinical and prognostic role of sarcopenia based on masticatory muscle index on MR images in patients with extranodal natural killer/T cell lymphoma, nasal type
Tianzi Xu, Yi Li, Yixin Liu, Biao Ning, Huijing Wu, Yongchang Wei
Endothelial activation and stress index as a prognostic factor of diffuse large B-cell lymphoma: the report from the nationwide multi-center Thai Lymphoma Study Group
Ronakrit Thanhakun, Kitsada Wudhikarn, Udomsak Bunworasate, Thanawat Rattanathammethee, Lalita Norasetthada, Piyapong Kanya, Juthatip Chaloemwong, Somchai Wongkhantee, Pisa Phiphitaporn, Kanchana Chansung, Dusit Jit-ueakul, Chonlada Laoruangroj, Kannadit Prayongratana, Peerapon Wong, Jakrawadee Julamanee, Arnuparp Lekhakula, Suporn Chuncharunee, Pimjai Niparuck, Nonglak Kanitsap, Nisa Makruasi, Tawatchai Suwanban, Pannee Praditsuktavorn, Archrob Khuhapinant, Tanin Intragumtornchai
Predictors of health-related quality of life of the patients treated for MM: the first study in the Palestinian healthcare system
Ramzi Shawahna, Riad Amer, Husam Salameh, Abdul-Rahman Shawahna, Mohmmad Aljondy, Mohmmad Zain-Aldain
The association of intestinal microbiota diversity and outcomes of allogeneic hematopoietic cell transplantation: a systematic review and meta-analysis
Shufen Wang, Xiaoyan Yue, Hongyu Zhou, Xu Chen, Huiqiao Chen, Liangning Hu, Wenjue Pan, Xiujie Zhao, Haowen Xiao
Effectiveness of single-dose 6 mg pegfilgrastim in mobilizing peripheral blood stem cells in allogeneic hematopoietic cell transplantation donors
Junjie Cao, Aizhen Li, Renzhi Pei, Ying Lu, Dong Chen, Xiaohong Du, Xuhui Liu, Shuangyue Li, Peipei Ye
IL-10 plus the EASIX score predict bleeding events after anti-CD19 CAR T-cell therapy
Xindi Wang, Chenggong Li, Wenjing Luo, Yinqiang Zhang, Zhongpei Huang, Jia Xu, Heng Mei, Yu Hu
Low incidence of severe acute and chronic graft-versus-host disease in a long-term retrospective study with ATG Grafalon routine use
Flora Kovacsova, Frantisek Folber, Barbora Weinbergerova, Radka Stepanova, Tomas Kabut, Miroslav Tomiska, Marta Krejci, Jiri Mayer
Epstein–Barr virus reactivation correlates with worse outcomes for patients exposed to hepatitis B virus after haploidentical hematopoietic stem cell transplantation
Jiajia Hu, Jie Zhao, Chunyan Wang, Mei Jia, Ming Su, Shanshan Li
Efficacy of venetoclax combined with decitabine conditioning regimen for allogeneic hematopoietic stem cell transplantation in high-risk and elderly patients with myeloid neoplasms
Xinhui Zheng, Hongye Gao, Ni Lu, Mingyang Wang, Haixiao Zhang, Yawei Zheng, Biao Shen, Yigeng Cao, Xin Chen, Weihua Zhai, Jialin Wei, Donglin Yang, Rongli Zhang, Aiming Pang, Sizhou Feng, Erlie Jiang, Mingzhe Han
Validation of venous thromboembolism predictive model in hematologic malignancies
Agnerys López Sacerio, Mara Caridad Tejeda Ramón, Aliuska Morales Helguera, Yunierkis Pérez Castillo, Javier Cruz Rodríguez, Jorge Felix Guerra Rodríguez, Anna Falanga
Discovering a novel pathogenic CDAN1 variant using exome sequencing and bioinformatics analysis
Ling-Hu Cai, Chuan-Chuan Liu, Tian Li, Yun-Ding Zou, Ming-Hua Liu, Qing Mao, Lu-Feng Li
Ibrutinib plus rituximab and lenalidomide for primary intestinal diffuse large B-cell lymphoma relapsed after anti-CD19 CAR-T cell therapy: a case report
Changyou Li, Xiyuan Zhang, Danni Zhu, Xiaocui Bu, Ling Wang, Peng Zhao
A case report of dyskeratosis congenita caused by a novel TERC mutation
Weiru Liang, Lei Ye, Fengkui Zhang
Clonal hematopoiesis with TET2 mutations spawning synchronous primary central nervous system lymphoma and myelodysplastic syndrome
Hannes Treiber, Christina Ganster, Julie Schanz, Joji Shimono, Sabrina Zechel, Nilofar Pohanyar, Christian Riedel, Christine Stadelmann, Detlef Haase, Lorenz Trümper, Björn Chapuy, Gerald G. Wulf
Diagnosis of sinusoidal obstruction syndrome: can biopsy be the key?
Oliver Kriege, Andreas Kreft, Beate Hauptrock, Pascal Wölfinger, Matthias Theobald, Eva-Maria Wagner-Drouet
Safe and successful teclistamab treatment in very elderly multiple myeloma (MM) patients: a case report and experience from a total of three octogenarians
Martin Philipp Dieterle, Gila Mostufi-Zadeh-Haghighi, Jan Wilhelm Kus, Christopher Wippel, Zacharias Brugger, Cornelius Miething, Ralph Wäsch, Monika Engelhardt
Clonal myeloid disorders following CAR T-cell therapy
Michael Andersen Jr, Poorva Bindal, Phillip Michaels, Pavania Elavalakanar, Jessica Liegel, Ajoy Dias, Jon Arnason, Rushad Patell
The role of ruxolitinib treatment in JAK-mutated Ph-like acute lymphoblastic leukemia
Ozlem Candan, Derya Demirtas, Ahmet Mert Yanik, Isik Atagunduz, Tayfur Toptas
Multiple myeloma relapse as extramedullary plasmacytoma of the penis
Henrique Coelho, Margarida Badior, Pedro Pinto, Ana Ribeiro, Márcio Tavares